Seeking Alpha

More on McKesson (MCK): FQ3 misses on the bottom line while beating total sales estimates,...

More on McKesson (MCK): FQ3 misses on the bottom line while beating total sales estimates, driven by higher medical-surgical distribution and services revenues. For FY13, EPS estimates are guided lower, now expected to be between $7.15 - 7.35 to $7.10 - 7.30 per share. Street estimates are for an EPS of $7.30. The company also says it's board has authorized an additional $500M to its stock buyback program. Shares -2.6% AH.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs